<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.2 20060430//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Neurosci</journal-id><journal-title>BMC Neuroscience</journal-title><issn pub-type="epub">1471-2202</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1471-2202-8-2</article-id><article-id pub-id-type="pmid">17199889</article-id><article-id pub-id-type="doi">10.1186/1471-2202-8-2</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Evidence for a wide extra-astrocytic distribution of S100B in human brain</article-title></title-group><contrib-group><contrib id="A1" corresp="yes" contrib-type="author"><name><surname>Steiner</surname><given-names>Johann</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>johann.steiner@medizin.uni-magdeburg.de</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Bernstein</surname><given-names>Hans-Gert</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>hans-gert.bernstein@medizin.uni-magdeburg.de</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Bielau</surname><given-names>Hendrik</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>hendrik.bielau@medizin.uni-magdeburg.de</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Berndt</surname><given-names>Annika</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>annika.berndt@web.de</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Brisch</surname><given-names>Ralf</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>ralfbrisch@hotmail.com</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Mawrin</surname><given-names>Christian</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>christian.mawrin@med.uni-jena.de</email></contrib><contrib id="A7" contrib-type="author"><name><surname>Keilhoff</surname><given-names>Gerburg</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>gerburg.keilhoff@medizin.uni-magdeburg.de</email></contrib><contrib id="A8" contrib-type="author"><name><surname>Bogerts</surname><given-names>Bernhard</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>bernhard.bogerts@medizin.uni-magdeburg.de</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Psychiatry, University of Magdeburg, Leipziger Str. 44, D-39120 Magdeburg, Germany</aff><aff id="I2"><label>2</label>Institute of Neuropathology, University of Jena, Erlanger Allee 101, D-07743 Jena, Germany</aff><aff id="I3"><label>3</label>Institute of Medical Neurobiology, University of Magdeburg, Leipziger Str. 44, D-39120 Magdeburg, Germany</aff><pub-date pub-type="collection"><year>2007</year></pub-date><pub-date pub-type="epub"><day>2</day><month>1</month><year>2007</year></pub-date><volume>8</volume><fpage>2</fpage><lpage>2</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2202/8/2"/><history><date date-type="received"><day>12</day><month>8</month><year>2006</year></date><date date-type="accepted"><day>2</day><month>1</month><year>2007</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2007 Steiner et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2007</copyright-year><copyright-holder>Steiner et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Steiner Johann johann.steiner@medizin.uni-magdeburg.de </dc:author><dc:title> Evidence for a wide extra-astrocytic distribution of S100B in human brain </dc:title><dc:date>2007</dc:date><dcterms:bibliographicCitation>BMC Neuroscience 8(1): 2-. (2007)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-2202(2007)8:1&#x0003c;2&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-2202</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>S100B is considered an astrocytic in-situ marker and protein levels in cerebrospinal fluid (CSF) or serum are often used as biomarker for astrocytic damage or dysfunction. However, studies on S100B in the human brain are rare. Thus, the distribution of S100B was studied by immunohistochemistry in adult human brains to evaluate its cell-type specificity.</p></sec><sec><title>Results</title><p>Contrary to glial fibrillary acidic protein (GFAP), which selectively labels astrocytes and shows only faint ependymal immunopositivity, a less uniform staining pattern was seen in the case of S100B. Cells with astrocytic morphology were primarily stained by S100B in the human cortex, while only 20% (14&#x02013;30%) or 14% (7&#x02013;35%) of all immunopositive cells showed oligodendrocytic morphology in the dorsolateral prefrontal and temporal cortices, respectively. In the white matter, however, most immunostained cells resembled oligodendrocytes [frontal: 75% (57&#x02013;85%); temporal: 73% (59&#x02013;87%); parietal: 79% (62&#x02013;89%); corpus callosum: 93% (86&#x02013;97%)]. S100B was also found in ependymal cells, the choroid plexus epithelium, vascular endothelial cells, lymphocytes, and several neurones. Anti-myelin basic protein (MBP) immunolabelling showed an association of S100B with myelinated fibres, whereas GFAP double staining revealed a distinct subpopulation of cells with astrocytic morphology, which solely expressed S100B but not GFAP. Some of these cells showed co-localization of S100B and A2B5 and may be characterized as O2A glial progenitor cells. However, S100B was not detected in microglial cells, as revealed by double-immunolabelling with HLA-DR.</p></sec><sec><title>Conclusion</title><p>S100B is localized in many neural cell-types and is less astrocyte-specific than GFAP. These are important results in order to avoid misinterpretation in the identification of normal and pathological cell types in situ and in clinical studies since S100B is continuously used as an astrocytic marker in animal models and various human diseases.</p></sec></abstract></article-meta></front><body><sec><title>1. Background</title><p>S100B protein is a Ca2+, Cu2+ and Zn2+ binding member of the S100-calmodulin-troponin superfamily and is primarily found in high abundance within the nervous system [<xref ref-type="bibr" rid="B1">1</xref>].</p><p>21 kDa homodimers are the predominant form in which the protein exists within cells. A number of intracellular growth-associated target proteins have been revealed, such as growth-associated protein 43 (GAP-43), the regulatory domain of protein kinase C (PKC), the anti-apoptotic factor Bcl-2 or the tumour suppressor protein P53 [<xref ref-type="bibr" rid="B2">2</xref>]. S100B has also been found to regulate protein ubiquitination via interaction with Sgt1 [<xref ref-type="bibr" rid="B3">3</xref>] and regulate the assembly of cytoskeleton components such as microtubules, glial fibrillary acidic protein (GFAP) or vimentin [<xref ref-type="bibr" rid="B4">4</xref>].</p><p>However, S100B is not only implicated in the regulation of intracellular processes, but, it is also a secretory protein and exhibits cytokine-like activities, which mediate the interactions among glial cells and between glial cells and neurones. These effects are induced, in part, by interaction of S100B with the receptor for advanced glycation end products (RAGE), a multiligand receptor that has been shown to transduce inflammatory stimuli and effects of several neurotrophic and neurotoxic factors [<xref ref-type="bibr" rid="B2">2</xref>]. Secretion of S100B from astrocytes is stimulated under metabolic stress (oxygen, serum and glucose deprivation) and is suppressed by glutamate [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>]. S100B acts in a dose-dependent manner: Nanomolar levels stimulate neurite growth and promote neurone survival. However, micromolar levels result in opposite effects and can even induce neuronal apoptosis, leading to the induction of pro-inflammatory cytokines such as interleukin1&#x003b2; (IL-1&#x003b2;) or tumour necrosis factor &#x003b1; (TNF-&#x003b1;), and inflammatory stress-related enzymes such as inducible nitric oxide synthase (iNOS) [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>].</p><p>High levels of S100B in cerebrospinal fluid (CSF) and peripheral blood have been observed in clinical research on Alzheimer's disease, stroke, traumatic brain injury, meningoencephalitis, mood disorders and schizophrenia [<xref ref-type="bibr" rid="B9">9</xref>-<xref ref-type="bibr" rid="B13">13</xref>]. Elevated levels of S100B have been increasingly considered a biomarker for astrocytic damage or dysfunction in this context. This may have arisen from several postmortem studies on Alzheimer's disease and Down's syndrome describing predominant S100B immunostaining in reactive astrocytes surrounding neuritic plaques [<xref ref-type="bibr" rid="B14">14</xref>-<xref ref-type="bibr" rid="B16">16</xref>]. Other studies on the cell-type specificity of S100B in human brain are rare [<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B18">18</xref>]. The cell-type specific localization of S100B in white matter has been minimally studied in human brain. However, higher contents of S100 have been found in white matter homogenates relative to cortex homogenates by the discoverer of the protein family [<xref ref-type="bibr" rid="B19">19</xref>].</p><p>In addition, it is sometimes overlooked that S100B containing cell types have also been identified outside the central nervous system and there are physiological stimuli for a release of S100B into the serum or CSF, which are not related to central nervous system diseases. Examples are physical exercise [<xref ref-type="bibr" rid="B20">20</xref>], stress [<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref>], fasting [<xref ref-type="bibr" rid="B23">23</xref>], critically ill patients [<xref ref-type="bibr" rid="B24">24</xref>], cardiac arrest [<xref ref-type="bibr" rid="B25">25</xref>] and extracranial injuries [<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B27">27</xref>] without brain injury.</p><p>The aim of the present work was to analyze the immunohistochemical distribution of S100B in adult human brain. We investigated telencephalic and diencephalic regions, including white matter of 14 healthy adults, to evaluate the cell-type specificity of S100B.</p></sec><sec><title>2. Results</title><sec><title>Western blot analysis</title><p>Using the S100B antibody obtained from DAKO, we observed a single strong band with a molecular mass of about 10 kDa, representing the authentic molecule, in human adult brain (Figure <xref ref-type="fig" rid="F1">1</xref>). This is in accordance with the immunoblotting analysis performed by the manufacturer of the antibody (DAKO, Glostrup, Denmark, see data sheet) using recombinant S100A1, S100A2, S100A4 and S100A6, where no cross-reaction with other S100 proteins was observed.</p></sec><sec><title>Preabsorption</title><p>No specific immunostaining was observed after preabsorption of the S100B antibody with the recombinant human-S100B protein.</p></sec><sec><title>Immunohistochemistry</title><p>The differential S100B- and GFAP-immunostaining pattern is summarized in Table <xref ref-type="table" rid="T1">1</xref> and <xref ref-type="table" rid="T2">2</xref>. GFAP immunohistochemistry selectively labelled astrocytes and their processes (Figure <xref ref-type="fig" rid="F2">2a</xref>), showed only faint ependymal immunopositivity and was negative in the choroid plexus epithelium (Figure <xref ref-type="fig" rid="F2">2e, g</xref>). In contrary, a less uniform staining pattern was seen in the case of S100B. Cells with astrocytic morphology in the human cortex primarily stained positive for S100B, while only 20% (14&#x02013;30%) or 14% (7&#x02013;35%) of all immunopositive cells showed oligodendrocytic morphology in the dorsolateral prefrontal and temporal cortex, respectively. In the white matter, however, most immunostained cells resembled oligodendrocytes [frontal: 75% (57&#x02013;85%); temporal: 73% (59&#x02013;87%); parietal: 79% (62&#x02013;89%); corpus callosum: 93% (86&#x02013;97%); Figure <xref ref-type="fig" rid="F2">2b, d</xref>]. Both GFAP- and S100B-immunostaining were seen in the subependymal layer and the perivascular (glia limitans) compartment and the perivascular membrane formed by astrocytic endfeet (Figure <xref ref-type="fig" rid="F2">2c, e, f</xref>). Of note, we observed strong S100B immunopositivity of the ependymal and choroids plexus epithelia (Figure <xref ref-type="fig" rid="F2">2f, h</xref>). In addition, S100B was also found in a few neurones and a subpopulation of lymphocytes (Figure <xref ref-type="fig" rid="F2">2i, k</xref>). By contrast, GFAP expression was detected neither in neurones nor in lymphocytes by the monoclonal antibody. The intracellular localization also varied: S100B was found in the nucleus and cytoplasm whereas GFAP was confined to the cytoplasm.</p></sec><sec><title>Double immunolabelling and immunofluorescence staining</title><p>Double immunolabelling revealed a distinct subpopulation of cells with astrocytic morphology, which were either positive for S100B or GFAP, or expressed both antigens (Figure <xref ref-type="fig" rid="F3">3a, b</xref>). Some of these were A2B5-immunopositive O2A glial progenitor cells (Figure <xref ref-type="fig" rid="F3">3f</xref>). S100B-positive fibres were also observed, which correspond to myelinated fibers as shown by double immunolabelling for S100B and MBP (Figure <xref ref-type="fig" rid="F3">3c, d</xref>). Oligodendrocytic S100B expression was confirmed by co-localization with MOG (Figure <xref ref-type="fig" rid="F3">3e</xref>). However, no microglial S100B immunolabelling was observed by HLA-DR double immunostaining (Figure <xref ref-type="fig" rid="F3">3g</xref>).</p></sec></sec><sec><title>3. Discussion and Conclusion</title><p>The cell-type specific localization of S100B in the brain has already been investigated in various species, including mouse, rat, cat, and lizard [<xref ref-type="bibr" rid="B28">28</xref>-<xref ref-type="bibr" rid="B33">33</xref>]. These studies found S100B in all glial cells, including astrocytes, ependymal cells, oligodendrocytes, microglial and Schwann cells. Studies on the cell-type specific expression of S100B in human brain are rare, but astrocytic and oligodendrocytic expression have been observed [<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B47">47</xref>]. Immunohistochemical postmortem studies on S100B in human temporal cortex in Alzheimer's disease and Down's syndrome may have led to the assumption that S100B is an astrocyte-specific marker (see introduction) [<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B44">44</xref>]. This is in accordance with our findings on grey matter, indicating a predominantly astrocytic S100B expression pattern in the dorsolateral prefrontal and temporal cortex of individuals without neurological or psychiatric disorders. However the majority of S100B immunopositive cells in the white matter resembled oligodendrocytes, which is in accordance with an early publication by Moore et al. (the discoverer of S100) who observed a higher content of S100 in white matter homogenates relative to cortical homogenates [<xref ref-type="bibr" rid="B19">19</xref>]. It has been demonstrated in rodents that S100B is primarily confined to immature oligodendrocytes, which may be activated in the context of a regenerative myelination processes [<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B34">34</xref>,<xref ref-type="bibr" rid="B35">35</xref>]. Deloulme et al. [<xref ref-type="bibr" rid="B28">28</xref>] detected S100B protein in up to 40% of MBP-positive oligodendrocytes in the corpus callosum of mice and Rickmann et al. [<xref ref-type="bibr" rid="B34">34</xref>] found an association of S100B with paranodal loops and outer mesaxons of myelin sheaths in rats by electron microscopic immunohistochemistry.</p><p>Microglial staining has only been detected in the rat by Adami et al. so far, but has not been observed in our present study on human brain [<xref ref-type="bibr" rid="B30">30</xref>]. Our study is the first reporting of a small subpopulation of S100B containing neurones in human brain tissue. This is in accordance with findings in the mouse [<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B36">36</xref>] and rat [<xref ref-type="bibr" rid="B33">33</xref>,<xref ref-type="bibr" rid="B37">37</xref>], but is in contrary to Li et al., who was unable to detect S100B immunopositive neurones in adult human brain [<xref ref-type="bibr" rid="B18">18</xref>]. Using a different antibody (mouse monoclonal anti-S100B from IBL, Minnesota) and the absence of antigen demasking techniques in the study by Li et al. might explain these different observations, as the importance of antigen retrieval methods to detect S100B immunopositive neurones has already been addressed by Yang et al. in mice [<xref ref-type="bibr" rid="B37">37</xref>].</p><p>Interestingly, the ependyma and the choroid plexus epithelia were strongly S100B immunopositive in our study as previously noted in the rat [<xref ref-type="bibr" rid="B38">38</xref>]. The surface ependyma is known to express epithelial markers and faint GFAP-staining. It is considered to be developmentally related to astrocytes, while the choroid plexus epithelium is a specialized ependyma, which differs from the surface ependyma: vimentin, cytokeratin and S100B continue to be expressed, but GFAP is not expressed [<xref ref-type="bibr" rid="B39">39</xref>]. Thus, the observed distribution pattern of S100B in the present study on human brain completely matches that reported in mouse and rat, indicating that cellular function might be very similar among mammalians.</p><p>Our study reveals a subpopulation of cells with astrocytic morphology, which were only immunopositive for S100B but not for GFAP. One explanation might be that some cells with astrocytic morphology were S100B- and A2B5-immunopositive O2A glial progenitor cells, which do not express GFAP [<xref ref-type="bibr" rid="B40">40</xref>].</p><p>In conclusion, S100B is a less astrocyte-specific marker than GFAP. Therefore, it should not be generally assumed that astrocytic damage or dysfunction is the main source for increased S100B concentrations in the case of studies with plasma, serum or cerebrospinal fluid. S100B may also be released during non-astrocyte cell death as it is also localized in O2A glial progenitor cells, oligodendrocytes, ependymal and plexus epithelial cells and neurones. In addition, S100B protein has also been noted outside the central nervous system. Immunocytochemical studies detected S100B in 5&#x02013;25% of CD8+ peripheral blood T cells [<xref ref-type="bibr" rid="B41">41</xref>], in adipose tissue, melanocytes, injured myocardium, satellite cells of dorsal root ganglia and Schwann-cells of the peripheral nervous system [<xref ref-type="bibr" rid="B2">2</xref>]. There is little information about the functional implications, but all these cell types are potential sources for S100B in serum.</p><p>In contrast, only minor sources of GFAP have been detected outside the central nervous system. Traces of GFAP have been found in the peripheral nervous system, macrophages, lymphocytes, lens epithelial cells, and few human breast myoepithelial cells [<xref ref-type="bibr" rid="B42">42</xref>-<xref ref-type="bibr" rid="B45">45</xref>]. Moreover, the peripheral GFAP is a shorter protein version and may be antigenically and structurally different, as <italic>monoclonal anti-brain </italic>GFAP antibodies have failed to recognize peripheral GFAP [<xref ref-type="bibr" rid="B46">46</xref>,<xref ref-type="bibr" rid="B47">47</xref>].</p><p>In summary, serum and CSF S100B, different from GFAP, has many putative cellular sources. This is important to avoid misinterpretation of normal and pathological cell type identifications in situ and in clinical studies since S100B is continuously used as an astrocytic marker in animal models and various human diseases.</p></sec><sec><title>4. Methods</title><sec><title>Human brain tissue for Western blot analysis and immunofluorescence staining</title><p>The brain of a 32 year old woman (who died from acute myocarditis associated with lupus) was removed from the cranium within 20 hrs after death, dissected into small pieces, snap-frozen in liquid nitrogen and stored.</p></sec><sec><title>Human brain tissue for immunohistochemistry</title><p>Postmortem brain tissue of 14 individuals without neurological or psychiatric disorders was used for the present study (mean age = 58.4 years; 7 males, 7 females). All brains were obtained from the Magdeburg Brain Collection. The collection of the human brain material was done in accordance with German laws and the rules outlined by the local ethics committee. Brains were removed within 48 hrs after death. The tissue preparation was performed as previously described [<xref ref-type="bibr" rid="B48">48</xref>]. Briefly, brains were fixed in toto in 8% phosphate-buffered formaldehyde (pH 7.0) for 3 months. After embedding the brains in paraplast, serial coronal 20 &#x003bc;m thick whole brain sections were cut on a microtome and mounted. For immunohistochemical staining, sections about 1 cm rostral to the genu of the corpus callosum and sections containing the hippocampus, as well as thalamus and lateral ventricles at the level of the mamillary bodies were selected.</p><p><italic>Blood smears </italic>from two healthy subjects were stained for S100B for closer identification of S100B immunopositive white blood cells, which were found in the vessels of brain sections. The blood smears were fixed in methanol for 1 h.</p></sec><sec><title>Western blot analysis</title><p>Frozen tissue samples from the temporal cortex and cerebellum was homogenized in lysis buffer [10 mM Tris (pH 7.4), 150 mM NaCl, 50 mM NaF, 1 mM EDTA, 1% Triton X-100, 0.1% SDS, 0.5% deoxycholat, 2.5 mM sodium pyrophosphate, 1 mM orthovanadate, 1 mM phenylmethylsulfonyl fluoride, 1 &#x003bc;g/ml leupeptin, and 10 &#x003bc;g/ml aprotinin, 1 mM DTT], and incubated on ice for 30 minutes. After centrifugation at 13,000 rpm for 15 minutes, the supernatant was collected to measure the total protein content. Protein concentration was measured by Bradford assay, with BSA as standard. Twenty micrograms of protein were loaded on 10% SDS-polyacrylamide gels for electrophoresis. After separation, proteins were transferred to a nitrocellulose membrane (Hybond C, Amersham Pharmacia Biotech, Freiburg, Germany) at 150 mA for 2 hours. Western blot analysis was done after blocking the membrane with 5% skim milk in TBST buffer for 1 hour. The membrane was incubated with the specific S100B antibody at 4&#x000b0;C overnight (DAKO, Glostrup, Denmark, dilution 1:500). The membrane was washed four times in TBST buffer. Secondary detection was performed using horseradish peroxidase-conjugated anti-rabbit immunoglobulin G (1:2,000; Amersham Pharmacia Biotech). After four washings with TBST, horseradish peroxidase activity was visualized by applying enhanced chemiluminescent substrate (Amersham Pharmacia Biotech) followed by exposure of the membrane to X-ray film.</p></sec><sec><title>Immunohistochemistry &#x02013; Single staining</title><p>Neighbouring sections were used for S100B or GFAP single-staining. Formalin-fixed tissue sections were deparaffinized and antigen demasking was performed by boiling the sections for 4 min in 10 mM citrate buffer (pH 6.0). Preincubation with 1.5% H<sub>2</sub>O<sub>2 </sub>for 10 min to block endogenous peroxidase activity was followed by blocking of nonspecific binding sites with 10% normal goat serum for 60 min and repeated washings with PBS. The primary antibody was diluted in PBS and applied for 48 h at 4&#x000b0;C (both antibodies were from DAKO, Glostrup, Denmark: polyclonal rabbit anti-recombinant human S100B, according to the manufacturer non cross-reactive with S100A1, S100A2, S100A4, and S100A6, dilution 1:50; monoclonal mouse anti-human brain glial fibrillary acidic protein (GFAP), dilution 1:100). Thereafter, sections were processed with the LSAB (labelled streptavidin biotin) method (DAKO, Glostrup, Denmark) and the reaction product was visualized with 3,3-diaminobenzidine. The colour reaction of the S100B staining was enhanced by adding 2 ml of a 0.5% (v/v) nickel ammonium sulphate solution to the diaminobenzidine [<xref ref-type="bibr" rid="B49">49</xref>]. <italic>Preabsorption</italic>: Specificity of the S100B immunoreaction was controlled by preabsorption of 2 ml antibody working dilution with 0.8 mg recombinant human-S100B (Biotrend, Cologne, Germany) for 24 h. No specific staining was observed after preabsorption with the protein. <italic>Double staining</italic>: Anti S100B primary antibody was applied for 48 h at 4&#x000b0;C. Thereafter, sections were incubated with EnVision Labelled Polymer (alkaline phosphatase-labelled anti-mouse and anti-rabbit antibodies, DAKO, Glostrup, Denmark) and the reaction product was visualized with Liquid permanent red (DAKO, Glostrup, Denmark). Subsequent GFAP immunostaining was performed according to the single-staining protocol after antibody elution with 0.1 M glycine-HCl for 10 min (pH 2.0). Counterstaining was performed with 50% (v/v) Harris Haematoxylin Solution (Sigma, St. Louis, USA) for 30 s.</p></sec><sec><title>Immunofluorescence staining</title><p>A tissue sample from the temporal cortex and adjacent white matter was fixed in 4% buffered paraformaldehyde (pH 7.4) at 4&#x000b0;C overnight, cryoprotected in a solution of 30% sucrose (Merck, Darmstadt, Germany) in 0.4% buffered paraformaldehyde (pH 7.4) for 2 days, and rapidly frozen at -20&#x000b0;C using 2-methylbutane (Roth, Karlsruhe, Germany). Serial sagittal 20 &#x003bc;m thick sections were cut on a cryostat (Jung Frigocut 2800 E, Leica, Bensheim, Germany).</p><p>Free-floating sections were washed and incubated with the corresponding antibodies: polyclonal rabbit anti-recombinant human S100B (DAKO, Glostrup, Denmark, dilution 1:50), monoclonal mouse anti-myelin basic protein (anti-MBP, Chemicon, Hampshire, United Kingdom, dilution 1:100), monoclonal mouse anti-myelin oligodendrocyte glycoprotein (anti-MOG, Chemicon, Hampshire, United Kingdom, dilution 1:500), monoclonal mouse anti-A2B5 (Chemicon, Hampshire, United Kingdom, dilution 1:100), or monoclonal mouse anti-human HLA-DR-alpha-chain (Clone TAL.1B5, DAKO, Glostrup, Denmark, dilution 1:1000) in PBS with 0.3% Triton X-100 and 1% normal goat serum overnight at 4&#x000b0;C. Following this, slices were washed in PBS (3 &#x000d7; 5 min) and incubated overnight with a combination of secondary antibodies (Molecular Probes, G&#x000f6;ttingen, Germany, dilution 1:500): goat anti-rabbit-IgG Alexa Fluor 546 or goat anti-mouse-IgG Alexa Fluor 488. Sections were examined using a fluorescence microscope (Axiophot, Zeiss, Germany) equipped with fluorescein, rhodamine and DAPI optics. Control reactions (substitution of the primary antisera with PBS) yielded negative results, i.e. no specific immunostaining was seen in these sections.</p><sec><title>Cytological classification</title><p>The <italic>cytological classification </italic>of immunopositive cells as neurones, astrocytes, oligodendrocytes or microglia was performed according to established cytomorphological criteria [<xref ref-type="bibr" rid="B50">50</xref>]: Neuronal nuclei are large, round with a single prominent nucleolus ("fried-egg" nuclei) and are surrounded by substantial cytoplasm. Astrocytes have less cytoplasm surrounding large, more or less rounded nuclei and exhibit many star-shaped processes. Fibrous astrocytes are found predominantly in the white matter; they possess numerous elongated processes. Protoplasmic astrocytes are present among collections of neuronal cell bodies (grey matter). Their processes are less numerous and considerably more swollen in appearance than those of fibrous astrocytes. Oligodendrocytes are associated with fibre tracts in typical "pearl necklet" alignment. They are small spheroid glial cells with round, lymphocyte-like nuclei, a small cytoplasmic rim and few processes (less than astrocytes).</p></sec></sec></sec><sec><title>Abbreviations</title><p>CSF: cerebrospinal fluid</p><p>DLPF: dorsolateral prefrontal</p><p>GAP-43: growth-associated protein 43</p><p>GFAP: glial fibrillary acidic protein</p><p>IL-1&#x003b2;: interleukin1&#x003b2;</p><p>iNOS: inducible nitric oxide synthase</p><p>MBP: myelin basic protein</p><p>MOG: myelin oligodendrocyte glycoprotein</p><p>PKC: protein kinase C</p><p>RAGE: receptor for advanced glycation end products</p><p>S.D.: standard deviation</p><p>TNF-&#x003b1;: tumour necrosis factor &#x003b1;</p></sec><sec><title>Authors' contributions</title><p>JS, HGB and BB conceived and designed the study. JS interpreted the results, performed the statistical analysis, created the figures and drafted the manuscript. AB and RB evaluated the slides. HB documented the results and contributed to the interpretation of results. CM performed the neuropathological examination and Western blot analysis. GK was responsible for the immunofluorescence staining. All authors read and approved the final manuscript.</p></sec></body><back><ack><sec><title>Acknowledgements</title><p>The Saxony-Anhalt Ministry of Research (XN3594O/0405M, N2-OGU), German Ministry of Research (BrainNet) and Stanley Foundation supported the present study. We thank Dr. Alan Richardson-Klavehn for revising the English language of the manuscript. Henrik Dobrowolny, Sieglinde Funke, Bianca Ketzler, Kathrin Paelchen and Renate Stauch provided excellent technical assistance.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>BW</given-names></name></person-group><article-title>A soluble protein characteristic of the nervous system</article-title><source>Biochem Biophys Res Commun</source><year>1965</year><volume>19</volume><fpage>739</fpage><lpage>744</lpage><pub-id pub-id-type="pmid">4953930</pub-id><pub-id pub-id-type="doi">10.1016/0006-291X(65)90320-7</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Donato</surname><given-names>R</given-names></name></person-group><article-title>S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles</article-title><source>Int J Biochem Cell Biol</source><year>2001</year><volume>33</volume><fpage>637</fpage><lpage>668</lpage><pub-id pub-id-type="pmid">11390274</pub-id><pub-id pub-id-type="doi">10.1016/S1357-2725(01)00046-2</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nowotny</surname><given-names>M</given-names></name><name><surname>Spiechowicz</surname><given-names>M</given-names></name><name><surname>Jastrzebska</surname><given-names>B</given-names></name><name><surname>Filipek</surname><given-names>A</given-names></name><name><surname>Kitagawa</surname><given-names>K</given-names></name><name><surname>Kuznicki</surname><given-names>J</given-names></name></person-group><article-title>Calcium-regulated interaction of Sgt1 with S100A6 (calcyclin) and other S100 proteins</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>26923</fpage><lpage>26928</lpage><pub-id pub-id-type="pmid">12746458</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M211518200</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bianchi</surname><given-names>R</given-names></name><name><surname>Giambanco</surname><given-names>I</given-names></name><name><surname>Donato</surname><given-names>R</given-names></name></person-group><article-title>S-100 protein, but not calmodulin, binds to the glial fibrillary acidic protein and inhibits its polymerization in a Ca(2+)-dependent manner</article-title><source>J Biol Chem</source><year>1993</year><volume>268</volume><fpage>12669</fpage><lpage>12674</lpage><pub-id pub-id-type="pmid">8509402</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gerlach</surname><given-names>R</given-names></name><name><surname>Demel</surname><given-names>G</given-names></name><name><surname>Konig</surname><given-names>HG</given-names></name><name><surname>Gross</surname><given-names>U</given-names></name><name><surname>Prehn</surname><given-names>JH</given-names></name><name><surname>Raabe</surname><given-names>A</given-names></name><name><surname>Seifert</surname><given-names>V</given-names></name><name><surname>Kogel</surname><given-names>D</given-names></name></person-group><article-title>Active secretion of S100B from astrocytes during metabolic stress</article-title><source>Neuroscience</source><year>2006</year><volume>141</volume><fpage>1697</fpage><lpage>1701</lpage><pub-id pub-id-type="pmid">16782283</pub-id><pub-id pub-id-type="doi">10.1016/j.neuroscience.2006.05.008</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tramontina</surname><given-names>F</given-names></name><name><surname>Leite</surname><given-names>MC</given-names></name><name><surname>Goncalves</surname><given-names>D</given-names></name><name><surname>Tramontina</surname><given-names>AC</given-names></name><name><surname>Souza</surname><given-names>DF</given-names></name><name><surname>Frizzo</surname><given-names>JK</given-names></name><name><surname>Nardin</surname><given-names>P</given-names></name><name><surname>Gottfried</surname><given-names>C</given-names></name><name><surname>Wofchuk</surname><given-names>ST</given-names></name><name><surname>Goncalves</surname><given-names>CA</given-names></name></person-group><article-title>High glutamate decreases S100B secretion by a mechanism dependent on the glutamate transporter</article-title><source>Neurochem Res</source><year>2006</year><volume>31</volume><fpage>815</fpage><lpage>820</lpage><pub-id pub-id-type="pmid">16794859</pub-id><pub-id pub-id-type="doi">10.1007/s11064-006-9085-z</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Ferreira</surname><given-names>A</given-names></name><name><surname>Van Eldik</surname><given-names>LJ</given-names></name></person-group><article-title>S100beta induces neuronal cell death through nitric oxide release from astrocytes</article-title><source>J Neurochem</source><year>1997</year><volume>69</volume><fpage>2294</fpage><lpage>2301</lpage><pub-id pub-id-type="pmid">9375660</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koppal</surname><given-names>T</given-names></name><name><surname>Lam</surname><given-names>AG</given-names></name><name><surname>Guo</surname><given-names>L</given-names></name><name><surname>Van Eldik</surname><given-names>LJ</given-names></name></person-group><article-title>S100B proteins that lack one or both cysteine residues can induce inflammatory responses in astrocytes and microglia</article-title><source>Neurochem Int</source><year>2001</year><volume>39</volume><fpage>401</fpage><lpage>407</lpage><pub-id pub-id-type="pmid">11578775</pub-id><pub-id pub-id-type="doi">10.1016/S0197-0186(01)00047-X</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lins</surname><given-names>H</given-names></name><name><surname>Wallesch</surname><given-names>CW</given-names></name><name><surname>Wunderlich</surname><given-names>MT</given-names></name></person-group><article-title>Sequential analyses of neurobiochemical markers of cerebral damage in cerebrospinal fluid and serum in CNS infections</article-title><source>Acta Neurol Scand</source><year>2005</year><volume>112</volume><fpage>303</fpage><lpage>308</lpage><pub-id pub-id-type="pmid">16218912</pub-id><pub-id pub-id-type="doi">10.1111/j.1600-0404.2005.00484.x</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peskind</surname><given-names>ER</given-names></name><name><surname>Griffin</surname><given-names>WS</given-names></name><name><surname>Akama</surname><given-names>KT</given-names></name><name><surname>Raskind</surname><given-names>MA</given-names></name><name><surname>Van Eldik</surname><given-names>LJ</given-names></name></person-group><article-title>Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease</article-title><source>Neurochem Int</source><year>2001</year><volume>39</volume><fpage>409</fpage><lpage>413</lpage><pub-id pub-id-type="pmid">11578776</pub-id><pub-id pub-id-type="doi">10.1016/S0197-0186(01)00048-1</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schroeter</surname><given-names>ML</given-names></name><name><surname>Abdul-Khaliq</surname><given-names>H</given-names></name><name><surname>Diefenbacher</surname><given-names>A</given-names></name><name><surname>Blasig</surname><given-names>IE</given-names></name></person-group><article-title>S100B is increased in mood disorders and may be reduced by antidepressive treatment</article-title><source>Neuroreport</source><year>2002</year><volume>13</volume><fpage>1675</fpage><lpage>1678</lpage><pub-id pub-id-type="pmid">12352625</pub-id><pub-id pub-id-type="doi">10.1097/00001756-200209160-00021</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Steiner</surname><given-names>J</given-names></name><name><surname>Bielau</surname><given-names>H</given-names></name><name><surname>Bernstein</surname><given-names>HG</given-names></name><name><surname>Bogerts</surname><given-names>B</given-names></name><name><surname>Wunderlich</surname><given-names>MT</given-names></name></person-group><article-title>Increased cerebrospinal fluid and serum levels of S100B in first-onset schizophrenia are not related to a degenerative release of glial fibrillar acidic protein, myelin basic protein and neurone-specific enolase from glia or neurones</article-title><source>J Neurol Neurosurg Psychiatry</source><year>2006</year><volume>77</volume><fpage>1284</fpage><lpage>1287</lpage><pub-id pub-id-type="pmid">17043297</pub-id><pub-id pub-id-type="doi">10.1136/jnnp.2006.093427</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wunderlich</surname><given-names>MT</given-names></name><name><surname>Ebert</surname><given-names>AD</given-names></name><name><surname>Kratz</surname><given-names>T</given-names></name><name><surname>Goertler</surname><given-names>M</given-names></name><name><surname>Jost</surname><given-names>S</given-names></name><name><surname>Herrmann</surname><given-names>M</given-names></name></person-group><article-title>Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage</article-title><source>Stroke</source><year>1999</year><volume>30</volume><fpage>1190</fpage><lpage>1195</lpage><pub-id pub-id-type="pmid">10356098</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sheng</surname><given-names>JG</given-names></name><name><surname>Mrak</surname><given-names>RE</given-names></name><name><surname>Griffin</surname><given-names>WS</given-names></name></person-group><article-title>S100 beta protein expression in Alzheimer disease: potential role in the pathogenesis of neuritic plaques</article-title><source>J Neurosci Res</source><year>1994</year><volume>39</volume><fpage>398</fpage><lpage>404</lpage><pub-id pub-id-type="pmid">7884819</pub-id><pub-id pub-id-type="doi">10.1002/jnr.490390406</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Griffin</surname><given-names>WS</given-names></name><name><surname>Stanley</surname><given-names>LC</given-names></name><name><surname>Ling</surname><given-names>C</given-names></name><name><surname>White</surname><given-names>L</given-names></name><name><surname>MacLeod</surname><given-names>V</given-names></name><name><surname>Perrot</surname><given-names>LJ</given-names></name><name><surname>White</surname><given-names>CL</given-names><suffix>3rd</suffix></name><name><surname>Araoz</surname><given-names>C</given-names></name></person-group><article-title>Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease</article-title><source>Proc Natl Acad Sci U S A</source><year>1989</year><volume>86</volume><fpage>7611</fpage><lpage>7615</lpage><pub-id pub-id-type="pmid">2529544</pub-id><pub-id pub-id-type="doi">10.1073/pnas.86.19.7611</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mrak</surname><given-names>RE</given-names></name><name><surname>Griffin</surname><given-names>WS</given-names></name></person-group><article-title>The role of activated astrocytes and of the neurotrophic cytokine S100B in the pathogenesis of Alzheimer's disease</article-title><source>Neurobiol Aging</source><year>2001</year><volume>22</volume><fpage>915</fpage><lpage>922</lpage><pub-id pub-id-type="pmid">11754999</pub-id><pub-id pub-id-type="doi">10.1016/S0197-4580(01)00293-7</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tiu</surname><given-names>SC</given-names></name><name><surname>Chan</surname><given-names>WY</given-names></name><name><surname>Heizmann</surname><given-names>CW</given-names></name><name><surname>Schafer</surname><given-names>BW</given-names></name><name><surname>Shu</surname><given-names>SY</given-names></name><name><surname>Yew</surname><given-names>DT</given-names></name></person-group><article-title>Differential expression of S100B and S100A6 in the human fetal and aged cerebral cortex</article-title><source>Brain Res Dev Brain Res</source><year>2000</year><volume>119</volume><fpage>159</fpage><lpage>168</lpage><pub-id pub-id-type="pmid">10675765</pub-id><pub-id pub-id-type="doi">10.1016/S0165-3806(99)00151-0</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>DR</given-names></name><name><surname>Zhu</surname><given-names>BL</given-names></name><name><surname>Ishikawa</surname><given-names>T</given-names></name><name><surname>Zhao</surname><given-names>D</given-names></name><name><surname>Michiue</surname><given-names>T</given-names></name><name><surname>Maeda</surname><given-names>H</given-names></name></person-group><article-title>Immunohistochemical distribution of S-100 protein in the cerebral cortex with regard to the cause of death in forensic autopsy</article-title><source>Leg Med (Tokyo)</source><year>2006</year><volume>8</volume><fpage>78</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">16338157</pub-id></citation></ref><ref id="B19"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>B</given-names></name><name><surname>Perez</surname><given-names>VJ</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Carlson FD</surname></name></person-group><article-title>Specific acidic proteins of the nervous system.</article-title><source>Physiological and Biochemical Aspects of Nervous Integration</source><year>1967</year><publisher-name>Englewood Cliffs, N.J., Prentice-Hall</publisher-name><fpage>343&#x02013;359</fpage></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dietrich</surname><given-names>MO</given-names></name><name><surname>Tort</surname><given-names>AB</given-names></name><name><surname>Schaf</surname><given-names>DV</given-names></name><name><surname>Farina</surname><given-names>M</given-names></name><name><surname>Goncalves</surname><given-names>CA</given-names></name><name><surname>Souza</surname><given-names>DO</given-names></name><name><surname>Portela</surname><given-names>LV</given-names></name></person-group><article-title>Increase in serum S100B protein level after a swimming race</article-title><source>Can J Appl Physiol</source><year>2003</year><volume>28</volume><fpage>710</fpage><lpage>716</lpage><pub-id pub-id-type="pmid">14710522</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Margis</surname><given-names>R</given-names></name><name><surname>Zanatto</surname><given-names>VC</given-names></name><name><surname>Tramontina</surname><given-names>F</given-names></name><name><surname>Vinade</surname><given-names>E</given-names></name><name><surname>Lhullier</surname><given-names>F</given-names></name><name><surname>Portela</surname><given-names>LV</given-names></name><name><surname>Souza</surname><given-names>DO</given-names></name><name><surname>Dalmaz</surname><given-names>C</given-names></name><name><surname>Kapczinski</surname><given-names>F</given-names></name><name><surname>Goncalves</surname><given-names>CA</given-names></name></person-group><article-title>Changes in S100B cerebrospinal fluid levels of rats subjected to predator stress</article-title><source>Brain Res</source><year>2004</year><volume>1028</volume><fpage>213</fpage><lpage>218</lpage><pub-id pub-id-type="pmid">15527746</pub-id><pub-id pub-id-type="doi">10.1016/j.brainres.2004.09.013</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scaccianoce</surname><given-names>S</given-names></name><name><surname>Del Bianco</surname><given-names>P</given-names></name><name><surname>Pannitteri</surname><given-names>G</given-names></name><name><surname>Passarelli</surname><given-names>F</given-names></name></person-group><article-title>Relationship between stress and circulating levels of S100B protein</article-title><source>Brain Res</source><year>2004</year><volume>1004</volume><fpage>208</fpage><lpage>211</lpage><pub-id pub-id-type="pmid">15033438</pub-id><pub-id pub-id-type="doi">10.1016/j.brainres.2004.01.028</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Netto</surname><given-names>CB</given-names></name><name><surname>Conte</surname><given-names>S</given-names></name><name><surname>Leite</surname><given-names>MC</given-names></name><name><surname>Pires</surname><given-names>C</given-names></name><name><surname>Martins</surname><given-names>TL</given-names></name><name><surname>Vidal</surname><given-names>P</given-names></name><name><surname>Benfato</surname><given-names>MS</given-names></name><name><surname>Giugliani</surname><given-names>R</given-names></name><name><surname>Goncalves</surname><given-names>CA</given-names></name></person-group><article-title>Serum S100B protein is increased in fasting rats</article-title><source>Arch Med Res</source><year>2006</year><volume>37</volume><fpage>683</fpage><lpage>686</lpage><pub-id pub-id-type="pmid">16740441</pub-id><pub-id pub-id-type="doi">10.1016/j.arcmed.2005.11.005</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Routsi</surname><given-names>C</given-names></name><name><surname>Stamataki</surname><given-names>E</given-names></name><name><surname>Nanas</surname><given-names>S</given-names></name><name><surname>Psachoulia</surname><given-names>C</given-names></name><name><surname>Stathopoulos</surname><given-names>A</given-names></name><name><surname>Koroneos</surname><given-names>A</given-names></name><name><surname>Zervou</surname><given-names>M</given-names></name><name><surname>Jullien</surname><given-names>G</given-names></name><name><surname>Roussos</surname><given-names>C</given-names></name></person-group><article-title>Increased levels of serum S100B protein in critically ill patients without brain injury</article-title><source>Shock</source><year>2006</year><volume>26</volume><fpage>20</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">16783193</pub-id><pub-id pub-id-type="doi">10.1097/01.shk.0000209546.06801.d7</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Piazza</surname><given-names>O</given-names></name><name><surname>Cotena</surname><given-names>S</given-names></name><name><surname>Esposito</surname><given-names>G</given-names></name><name><surname>De Robertis</surname><given-names>E</given-names></name><name><surname>Tufano</surname><given-names>R</given-names></name></person-group><article-title>S100B is a sensitive but not specific prognostic index in comatose patients after cardiac arrest</article-title><source>Minerva Chir</source><year>2005</year><volume>60</volume><fpage>477</fpage><lpage>480</lpage><pub-id pub-id-type="pmid">16402001</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Savola</surname><given-names>O</given-names></name><name><surname>Pyhtinen</surname><given-names>J</given-names></name><name><surname>Leino</surname><given-names>TK</given-names></name><name><surname>Siitonen</surname><given-names>S</given-names></name><name><surname>Niemela</surname><given-names>O</given-names></name><name><surname>Hillbom</surname><given-names>M</given-names></name></person-group><article-title>Effects of head and extracranial injuries on serum protein S100B levels in trauma patients</article-title><source>J Trauma</source><year>2004</year><volume>56</volume><fpage>1229</fpage><lpage>34; discussion 1234</lpage><pub-id pub-id-type="pmid">15211130</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Unden</surname><given-names>J</given-names></name><name><surname>Bellner</surname><given-names>J</given-names></name><name><surname>Eneroth</surname><given-names>M</given-names></name><name><surname>Alling</surname><given-names>C</given-names></name><name><surname>Ingebrigtsen</surname><given-names>T</given-names></name><name><surname>Romner</surname><given-names>B</given-names></name></person-group><article-title>Raised serum S100B levels after acute bone fractures without cerebral injury</article-title><source>J Trauma</source><year>2005</year><volume>58</volume><fpage>59</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">15674151</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Deloulme</surname><given-names>JC</given-names></name><name><surname>Raponi</surname><given-names>E</given-names></name><name><surname>Gentil</surname><given-names>BJ</given-names></name><name><surname>Bertacchi</surname><given-names>N</given-names></name><name><surname>Marks</surname><given-names>A</given-names></name><name><surname>Labourdette</surname><given-names>G</given-names></name><name><surname>Baudier</surname><given-names>J</given-names></name></person-group><article-title>Nuclear expression of S100B in oligodendrocyte progenitor cells correlates with differentiation toward the oligodendroglial lineage and modulates oligodendrocytes maturation</article-title><source>Mol Cell Neurosci</source><year>2004</year><volume>27</volume><fpage>453</fpage><lpage>465</lpage><pub-id pub-id-type="pmid">15555923</pub-id><pub-id pub-id-type="doi">10.1016/j.mcn.2004.07.008</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vives</surname><given-names>V</given-names></name><name><surname>Alonso</surname><given-names>G</given-names></name><name><surname>Solal</surname><given-names>AC</given-names></name><name><surname>Joubert</surname><given-names>D</given-names></name><name><surname>Legraverend</surname><given-names>C</given-names></name></person-group><article-title>Visualization of S100B-positive neurons and glia in the central nervous system of EGFP transgenic mice</article-title><source>J Comp Neurol</source><year>2003</year><volume>457</volume><fpage>404</fpage><lpage>419</lpage><pub-id pub-id-type="pmid">12561079</pub-id><pub-id pub-id-type="doi">10.1002/cne.10552</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adami</surname><given-names>C</given-names></name><name><surname>Sorci</surname><given-names>G</given-names></name><name><surname>Blasi</surname><given-names>E</given-names></name><name><surname>Agneletti</surname><given-names>AL</given-names></name><name><surname>Bistoni</surname><given-names>F</given-names></name><name><surname>Donato</surname><given-names>R</given-names></name></person-group><article-title>S100B expression in and effects on microglia</article-title><source>Glia</source><year>2001</year><volume>33</volume><fpage>131</fpage><lpage>142</lpage><pub-id pub-id-type="pmid">11180510</pub-id><pub-id pub-id-type="doi">10.1002/1098-1136(200102)33:2&#x0003c;131::AID-GLIA1012&#x0003e;3.0.CO;2-D</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dyck</surname><given-names>RH</given-names></name><name><surname>Van Eldik</surname><given-names>LJ</given-names></name><name><surname>Cynader</surname><given-names>MS</given-names></name></person-group><article-title>Immunohistochemical localization of the S-100 beta protein in postnatal cat visual cortex: spatial and temporal patterns of expression in cortical and subcortical glia</article-title><source>Brain Res Dev Brain Res</source><year>1993</year><volume>72</volume><fpage>181</fpage><lpage>192</lpage><pub-id pub-id-type="pmid">8485842</pub-id><pub-id pub-id-type="doi">10.1016/0165-3806(93)90183-B</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Romero-Aleman</surname><given-names>MM</given-names></name><name><surname>Monzon-Mayor</surname><given-names>M</given-names></name><name><surname>Yanes</surname><given-names>C</given-names></name><name><surname>Arbelo-Galvan</surname><given-names>JF</given-names></name><name><surname>Lang</surname><given-names>D</given-names></name><name><surname>Renau-Piqueras</surname><given-names>J</given-names></name><name><surname>Negrin-Martinez</surname><given-names>C</given-names></name></person-group><article-title>S100 immunoreactive glial cells in the forebrain and midbrain of the lizard Gallotia galloti during ontogeny</article-title><source>J Neurobiol</source><year>2003</year><volume>57</volume><fpage>54</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">12973828</pub-id><pub-id pub-id-type="doi">10.1002/neu.10258</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rickmann</surname><given-names>M</given-names></name><name><surname>Wolff</surname><given-names>JR</given-names></name></person-group><article-title>S100 protein expression in subpopulations of neurons of rat brain</article-title><source>Neuroscience</source><year>1995</year><volume>67</volume><fpage>977</fpage><lpage>991</lpage><pub-id pub-id-type="pmid">7675218</pub-id><pub-id pub-id-type="doi">10.1016/0306-4522(94)00615-C</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rickmann</surname><given-names>M</given-names></name><name><surname>Wolff</surname><given-names>JR</given-names></name></person-group><article-title>S100 immunoreactivity in a subpopulation of oligodendrocytes and Ranvier's nodes of adult rat brain</article-title><source>Neurosci Lett</source><year>1995</year><volume>186</volume><fpage>13</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">7783941</pub-id><pub-id pub-id-type="doi">10.1016/0304-3940(95)11269-3</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hachem</surname><given-names>S</given-names></name><name><surname>Aguirre</surname><given-names>A</given-names></name><name><surname>Vives</surname><given-names>V</given-names></name><name><surname>Marks</surname><given-names>A</given-names></name><name><surname>Gallo</surname><given-names>V</given-names></name><name><surname>Legraverend</surname><given-names>C</given-names></name></person-group><article-title>Spatial and temporal expression of S100B in cells of oligodendrocyte lineage</article-title><source>Glia</source><year>2005</year><volume>51</volume><fpage>81</fpage><lpage>97</lpage><pub-id pub-id-type="pmid">15782413</pub-id><pub-id pub-id-type="doi">10.1002/glia.20184</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Friend</surname><given-names>WC</given-names></name><name><surname>Clapoff</surname><given-names>S</given-names></name><name><surname>Landry</surname><given-names>C</given-names></name><name><surname>Becker</surname><given-names>LE</given-names></name><name><surname>O'Hanlon</surname><given-names>D</given-names></name><name><surname>Allore</surname><given-names>RJ</given-names></name><name><surname>Brown</surname><given-names>IR</given-names></name><name><surname>Marks</surname><given-names>A</given-names></name><name><surname>Roder</surname><given-names>J</given-names></name><name><surname>Dunn</surname><given-names>RJ</given-names></name></person-group><article-title>Cell-specific expression of high levels of human S100 beta in transgenic mouse brain is dependent on gene dosage</article-title><source>J Neurosci</source><year>1992</year><volume>12</volume><fpage>4337</fpage><lpage>4346</lpage><pub-id pub-id-type="pmid">1432098</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Q</given-names></name><name><surname>Hamberger</surname><given-names>A</given-names></name><name><surname>Hyden</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Stigbrand</surname><given-names>T</given-names></name><name><surname>Haglid</surname><given-names>KG</given-names></name></person-group><article-title>S-100 beta has a neuronal localisation in the rat hindbrain revealed by an antigen retrieval method</article-title><source>Brain Res</source><year>1995</year><volume>696</volume><fpage>49</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">8574684</pub-id><pub-id pub-id-type="doi">10.1016/0006-8993(95)00755-F</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cocchia</surname><given-names>D</given-names></name></person-group><article-title>Immunocytochemical localization of S-100 protein in the brain of adult rat. An ultrastructural study</article-title><source>Cell Tissue Res</source><year>1981</year><volume>214</volume><fpage>529</fpage><lpage>540</lpage><pub-id pub-id-type="pmid">7214465</pub-id><pub-id pub-id-type="doi">10.1007/BF00233493</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sarnat</surname><given-names>HB</given-names></name></person-group><article-title>Histochemistry and immunocytochemistry of the developing ependyma and choroid plexus</article-title><source>Microsc Res Tech</source><year>1998</year><volume>41</volume><fpage>14</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">9550134</pub-id><pub-id pub-id-type="doi">10.1002/(SICI)1097-0029(19980401)41:1&#x0003c;14::AID-JEMT3&#x0003e;3.0.CO;2-U</pub-id></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Rao</surname><given-names>MS</given-names></name></person-group><article-title>Glial progenitors in the CNS and possible lineage relationships among them</article-title><source>Biol Cell</source><year>2004</year><volume>96</volume><fpage>279</fpage><lpage>290</lpage><pub-id pub-id-type="pmid">15145532</pub-id><pub-id pub-id-type="doi">10.1016/j.biolcel.2004.02.001</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>K</given-names></name><name><surname>Ohtsuki</surname><given-names>Y</given-names></name><name><surname>Sonobe</surname><given-names>H</given-names></name><name><surname>Hayashi</surname><given-names>K</given-names></name></person-group><article-title>Immunocytochemical characterization of S-100 beta-positive human T-lymphocytes by a double immunostaining method</article-title><source>Virchows Arch B Cell Pathol Incl Mol Pathol</source><year>1987</year><volume>53</volume><fpage>375</fpage><lpage>377</lpage><pub-id pub-id-type="pmid">2446420</pub-id></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alliot</surname><given-names>F</given-names></name><name><surname>Pessac</surname><given-names>B</given-names></name></person-group><article-title>Macrophages express glial markers</article-title><source>Biol Cell</source><year>1988</year><volume>63</volume><fpage>109</fpage><lpage>111</lpage><pub-id pub-id-type="pmid">2461238</pub-id><pub-id pub-id-type="doi">10.1016/0248-4900(88)90115-3</pub-id></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Riol</surname><given-names>H</given-names></name><name><surname>Tardy</surname><given-names>M</given-names></name><name><surname>Rolland</surname><given-names>B</given-names></name><name><surname>Levesque</surname><given-names>G</given-names></name><name><surname>Murthy</surname><given-names>MR</given-names></name></person-group><article-title>Detection of the peripheral nervous system (PNS)-type glial fibrillary acidic protein (GFAP) and its mRNA in human lymphocytes</article-title><source>J Neurosci Res</source><year>1997</year><volume>48</volume><fpage>53</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">9086181</pub-id><pub-id pub-id-type="doi">10.1002/(SICI)1097-4547(19970401)48:1&#x0003c;53::AID-JNR5&#x0003e;3.0.CO;2-D</pub-id></citation></ref><ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boyer</surname><given-names>S</given-names></name><name><surname>Montagutelli</surname><given-names>X</given-names></name><name><surname>Gomes</surname><given-names>D</given-names></name><name><surname>Simon-Chazottes</surname><given-names>D</given-names></name><name><surname>Guenet</surname><given-names>JL</given-names></name><name><surname>Dupouey</surname><given-names>P</given-names></name></person-group><article-title>Recent evolutionary origin of the expression of the glial fibrillary acidic protein (GFAP) in lens epithelial cells. A molecular and genetic analysis of various mouse species</article-title><source>Brain Res Mol Brain Res</source><year>1991</year><volume>10</volume><fpage>159</fpage><lpage>166</lpage><pub-id pub-id-type="pmid">1712888</pub-id><pub-id pub-id-type="doi">10.1016/0169-328X(91)90106-8</pub-id></citation></ref><ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Viale</surname><given-names>G</given-names></name><name><surname>Gambacorta</surname><given-names>M</given-names></name><name><surname>Coggi</surname><given-names>G</given-names></name><name><surname>Dell'Orto</surname><given-names>P</given-names></name><name><surname>Milani</surname><given-names>M</given-names></name><name><surname>Doglioni</surname><given-names>C</given-names></name></person-group><article-title>Glial fibrillary acidic protein immunoreactivity in normal and diseased human breast</article-title><source>Virchows Arch A Pathol Anat Histopathol</source><year>1991</year><volume>418</volume><fpage>339</fpage><lpage>348</lpage><pub-id pub-id-type="pmid">1708927</pub-id><pub-id pub-id-type="doi">10.1007/BF01600164</pub-id></citation></ref><ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jessen</surname><given-names>KR</given-names></name><name><surname>Thorpe</surname><given-names>R</given-names></name><name><surname>Mirsky</surname><given-names>R</given-names></name></person-group><article-title>Molecular identity, distribution and heterogeneity of glial fibrillary acidic protein: an immunoblotting and immunohistochemical study of Schwann cells, satellite cells, enteric glia and astrocytes</article-title><source>J Neurocytol</source><year>1984</year><volume>13</volume><fpage>187</fpage><lpage>200</lpage><pub-id pub-id-type="pmid">6726286</pub-id><pub-id pub-id-type="doi">10.1007/BF01148114</pub-id></citation></ref><ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mokuno</surname><given-names>K</given-names></name><name><surname>Kamholz</surname><given-names>J</given-names></name><name><surname>Behrman</surname><given-names>T</given-names></name><name><surname>Black</surname><given-names>C</given-names></name><name><surname>Sessa</surname><given-names>M</given-names></name><name><surname>Feinstein</surname><given-names>D</given-names></name><name><surname>Lee</surname><given-names>V</given-names></name><name><surname>Pleasure</surname><given-names>D</given-names></name></person-group><article-title>Neuronal modulation of Schwann cell glial fibrillary acidic protein (GFAP)</article-title><source>J Neurosci Res</source><year>1989</year><volume>23</volume><fpage>396</fpage><lpage>405</lpage><pub-id pub-id-type="pmid">2769798</pub-id><pub-id pub-id-type="doi">10.1002/jnr.490230405</pub-id></citation></ref><ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Steiner</surname><given-names>J</given-names></name><name><surname>Mawrin</surname><given-names>C</given-names></name><name><surname>Ziegeler</surname><given-names>A</given-names></name><name><surname>Bielau</surname><given-names>H</given-names></name><name><surname>Ullrich</surname><given-names>O</given-names></name><name><surname>Bernstein</surname><given-names>HG</given-names></name><name><surname>Bogerts</surname><given-names>B</given-names></name></person-group><article-title>Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization</article-title><source>Acta Neuropathol</source><year>2006</year><volume>112</volume><fpage>305</fpage><lpage>316</lpage><pub-id pub-id-type="pmid">16783554</pub-id><pub-id pub-id-type="doi">10.1007/s00401-006-0090-8</pub-id></citation></ref><ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>SM</given-names></name><name><surname>Soban</surname><given-names>E</given-names></name></person-group><article-title>Color modification of diaminobenzidine (DAB) precipitation by metallic ions and its application for double immunohistochemistry</article-title><source>J Histochem Cytochem</source><year>1982</year><volume>30</volume><fpage>1079</fpage><lpage>1082</lpage><pub-id pub-id-type="pmid">6182185</pub-id></citation></ref><ref id="B50"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Polak</surname><given-names>M</given-names></name><name><surname>Haymaker</surname><given-names>W</given-names></name><name><surname>Johnson</surname><given-names>JE</given-names></name><name><surname>D&#x000b4;Amelio</surname><given-names>F</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Haymaker W and Adams RD</surname></name></person-group><article-title>Neuroglia and their reactions</article-title><source>Histology and Histopathology of the Nervous System</source><year>1982</year><volume>1</volume><publisher-name>Springfield, Charles C. Thomas Publishing</publisher-name><fpage>363</fpage><lpage>480</lpage></citation></ref></ref-list><sec sec-type="display-objects"><title>Figures and Tables</title><fig position="float" id="F1"><label>Figure 1</label><caption><p>S100B immunoblot (DAKO, Glostrup, Denmark, dilution 1:500) indicating a single band of S100B protein in human brain homogenates.</p></caption><graphic xlink:href="1471-2202-8-2-1"/></fig><fig position="float" id="F2"><label>Figure 2</label><caption><p><bold>GFAP- and S100B-single immunostaining</bold>. <bold>(a) </bold>GFAP immunohistochemistry of the border between temporal cortex and adjacent white matter selectively labels star-shaped astrocytes and their processes. Blood vessels appear to be GFAP-positive because of their close association with pericapillary endfeet. <bold>(b) </bold>In contrast, various glial cell types are expressing S100B in this brain region, such as star-shaped cells with astrocytic morphology (black arrow) and spheroid cells with oligodendrocytic morphology (white arrow). <bold>(c) </bold>S100B stained astrocytic end feet (arrow: glial perivascular membrane) surround vascular endothelial cells. <bold>(d) </bold>"Pearl necklet" alignment of S100B positive (black arrow) and negative (white arrow) cells with oligodendrocytic morphology are associated with fibre tracts of the corpus callosum. Cytoplasmic and nuclear distribution of S100B is shown in the detail-picture. <bold>(e) </bold>The ependymal layer [E] around the lateral ventricle shows only weak GFAP staining, whereas the subependymal layer [S] shows intense staining of astrocytes and astrocytic processes. <bold>(f) </bold>Strongly S100B immunopositive ependymal [E] and subependymal [S] layers around the lateral ventricle. <bold>(g) </bold>Ependymal cells of the choroid plexus do not express GFAP but are heavily stained for S100B <bold>(h)</bold>; some S100B-positive cells display apical secrete granules; arrows indicate cells with cytoplasmic versus cytoplasmic and nuclear S100B expression. <bold>(i) </bold>S100B immunopositive CA1 hippocampal neurone. Neurones are rarely S100B positive. <bold>(k) </bold>S100B immunopositive lymphocytes and vascular smooth muscle cells. The detail picture shows a S100B stained lymphocyte from a blood smear. Bars: <bold>a, b </bold>= 100 &#x003bc;m; <bold>d, e, f, g, h, I, k </bold>= 50 &#x003bc;m; <bold>c, d (detail), k (detail) </bold>= 20 &#x003bc;m.</p></caption><graphic xlink:href="1471-2202-8-2-2"/></fig><fig position="float" id="F3"><label>Figure 3</label><caption><p><bold>Double immunostaining and immunofluorescence staining</bold>. <bold>(a) </bold>S100B (red)/GFAP (black) double immunolabelling with haematoxylin-counterstaining (blue) revealed distinct populations of cells with astrocytic morphology in the temporal cortex. White arrows indicate S100B single positive cells with astrocytic morphology; black arrows indicate GFAP immunopositive cells with astrocytic morphology. <bold>(b) </bold>Temporal brain region (overview): The majority of GFAP immunopositive (black) astrocytes were found in the glial limitans and perivascular membrane or in the adjacent white matter. Less GFAP immunopositive cells were observed in the cortex. <bold>(c) </bold>Temporal cortex and adjacent white matter (higher magnification): S100B positive (red) radial fibres and oligodendrocytes (white arrows) are shown in comparison to GFAP positive (black) astrocytes; haematoxylin-counterstaining (blue). <bold>(d) </bold>Co-localization (yellow) of S100B (red) and MBP-positive (green) myelinated fibres, extending from the temporal cortex to the adjacent white matter. <bold>(e) </bold>Co-localization (yellow) of S100B (red) and MOG-positive (green) oligodendrocytes. <bold>(f) </bold>Co-localization (yellow) of S100B (red) and A2B5-immunopositive (green) O2A glial progenitor cells in the temporal cortex. <bold>(g) </bold>No co-localization (yellow) was observed for S100B (red) and microglial HLA-DR (green). Bars: <bold>a </bold>= 100 &#x003bc;m; <bold>b </bold>= 500 &#x003bc;m; <bold>c </bold>= 30 &#x003bc;m.</p></caption><graphic xlink:href="1471-2202-8-2-3"/></fig><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Cell-type specific S100B- and GFAP-immunostaining pattern. <italic>Annotation</italic>: &#x02205; immunonegative, + faint immunostaining, ++ strong immunostaining</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left"><bold>Cell type</bold></td><td align="center"><bold>S100B</bold></td><td align="center"><bold>GFAP</bold></td></tr></thead><tbody><tr><td align="left"><bold>Astrocytes</bold></td><td align="center">++, cytoplasm/nuclei</td><td align="center">++, cytoplasm and processes</td></tr><tr><td align="left"><bold>Oligodendrocytes</bold></td><td align="center">++, cytoplasm/nuclei</td><td align="center">&#x02205;</td></tr><tr><td align="left"><bold>Neurones</bold></td><td align="center">very few +, cytoplasm/nuclei</td><td align="center">&#x02205;</td></tr><tr><td align="left"><bold>Ependyma</bold></td><td align="center">++, cytoplasm/nuclei</td><td align="center">+, cytoplasm</td></tr><tr><td align="left"><bold>Choroid plexus epithelium</bold></td><td align="center">++, cytoplasm/nuclei</td><td align="center">&#x02205;</td></tr><tr><td align="left"><bold>Lymphocytes</bold></td><td align="center">++, cytoplasm/nuclei</td><td align="center">&#x02205;</td></tr></tbody></table></table-wrap><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Quantification of S100B immunopositive cells with astrocytic <italic>versus </italic>oligodendrocytic morphology. <italic>Annotation</italic>: Values are given as mean &#x000b1; S.D.; <italic>DLPF </italic>dorsolateral prefrontal</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center"><bold>Brain region</bold></td><td align="center"><bold>Oligodendrocytic S100B+ [cells/mm<sup>3</sup>]</bold></td><td align="center"><bold>Astrocytic S100B+ [cells/mm<sup>3</sup>]</bold></td><td align="center"><bold>Oligodendrocytic S100B+ cells [mean % of all S100B+ glial cells (min % &#x02013; max %)]</bold></td></tr></thead><tbody><tr><td align="center"><bold>DLPF cortex</bold></td><td align="center">1.247 &#x000b1; 672</td><td align="center">5.066 &#x000b1; 2.674</td><td align="center">20 (14 &#x02013; 30)</td></tr><tr><td align="center"><bold>DLPF white matter</bold></td><td align="center">14.423 &#x000b1; 7.061</td><td align="center">4.462 &#x000b1; 2.376</td><td align="center">75 (57 &#x02013; 85)</td></tr><tr><td align="center"><bold>Temporal cortex</bold></td><td align="center">1.207 &#x000b1; 860</td><td align="center">7.457 &#x000b1; 3.964</td><td align="center">14 (7 &#x02013; 35)</td></tr><tr><td align="center"><bold>Temporal white matter</bold></td><td align="center">11.229 &#x000b1; 5.085</td><td align="center">3.919 &#x000b1; 2.310</td><td align="center">73 (59 &#x02013; 87)</td></tr><tr><td align="center"><bold>Parietal white matter</bold></td><td align="center">9.279 &#x000b1; 4.074</td><td align="center">2.346 &#x000b1; 1.357</td><td align="center">79 (62 &#x02013; 89)</td></tr><tr><td align="center"><bold>Corpus callosum</bold></td><td align="center">10.038 &#x000b1; 4.533</td><td align="center">674 &#x000b1; 338</td><td align="center">93 (86 &#x02013; 97)</td></tr></tbody></table></table-wrap></sec></back></article> 